Risedronate

FDA Approved: * October 5, 2007
Pharm Company: * TEVA PHARMS
Category: Osteoporosis

Risedronic acid, often used as its sodium salt risedronate sodium, is a bisphosphonate. It slows down the cells which break down bone. It's used to treat or prevent osteoporosis, and treat Paget's disease of bone. It is taken by mouth. It was patented in 1984 and approved for medical use in 1998.[1] Contents 1 Pharmacology 2 Society and culture 2.1 Brand names 2.2 Controversies 3 References 4 External links Pharmacology Relative potency[2] Bisphosp... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
6 Discussions

Dosage List

Risedronate TEVA;7389
Risedronate Sodium 35 mg Oral Tablet, Film Coated
NDC: 0093-3098
Labeler:
Teva Pharmaceuticals USA Inc
Risedronate TEVA;7390
Risedronate Sodium 5 mg Oral Tablet, Film Coated
NDC: 0093-3099
Labeler:
Teva Pharmaceuticals USA Inc
Risedronate TEVA;7391
Risedronate Sodium 30 mg Oral Tablet, Film Coated
NDC: 0093-3100
Labeler:
Teva Pharmaceuticals USA Inc
Risedronate T21
Risedronate Sodium 35 mg Oral Tablet, Delayed Release
NDC: 0093-5509
Labeler:
Teva Pharmaceuticals USA Inc
Risedronate APO;RIS;150
Risedronate Sodium 150 mg Oral Tablet, Film Coated
NDC: 60505-3097
Labeler:
Apotex Corp.
Risedronate Sodium 150 mg Oral Tablet, Film Coated
NDC: 0093-7771
Labeler:
Teva Pharmaceuticals USA, Inc.
Risedronate Sodium 5 mg Oral Tablet, Film Coated
NDC: 0378-4044
Labeler:
Mylan Pharmaceuticals Inc.
Risedronate Sodium 30 mg Oral Tablet, Film Coated
NDC: 0378-4114
Labeler:
Mylan Pharmaceuticals Inc.
Risedronate Sodium 150 mg Oral Tablet, Film Coated
NDC: 0378-4150
Labeler:
Mylan Pharmaceuticals Inc.
Risedronate Sodium 35 mg Oral Tablet, Film Coated
NDC: 0378-4714
Labeler:
Mylan Pharmaceuticals Inc.
More Results

Related Brands

Drugs with the same active ingredients